When fetal urinary-tract malformations (UTM) are discovered, managemen
t is based on the prediction of postnatal renal function, currently ma
de by fetal urinary biochemistry and sonography, Serum beta(2)-microgl
obulin has been used postnatally to estimate renal function and does n
ot cross the placenta. We investigated the relation between fetal seru
m beta(2)-microglobulin and renal function by comparing 64 unaffected
fetuses and 15 fetuses with UTM. A beta(2)-microglobulin above a 5.6 m
g/L cut-off gave cross-validated sensitivity of 88.9%, specificity of
98.6%, a positive predictive value of 88.9%, and a negative predictive
value of 97.1% for our cohort study.